Close×

Mobile app Shazam has announced a partnership with Nestlé which makes KitKat packaging interactive.

The effort will see millions of Shazam-enabled KitKat bars distributed as part of the consumer promotion.

The KitKat team have asked consumers to join ‘The Breakers Party’ for the chance to win “the break of a lifetime”.

By entering the competition consumers also have the chance to be awarded the ‘spoof title’ of Minister for Shopping, Tech, Music, Travel or Sports, with prizes valued up to $23,000 towards their chosen break.

Shoppers have been asked to 'Shazam' the packaging, go to the website, and follow the prompts.

A visual recognition capability was launched in June last year as part of Shazam’s broader 'Shazam Connect for Brands' product offering.

When coupled with the app's existing audio recognition capabilities, it allows marketers to make all consumer-facing touch points clickable, including traditional media, POS and packaging, to build a bridge from physical to digital.

There will be over 4.7 million Shazam-enabled KitKat bars in the Australian market.

The promotion is being rolled out via Shazam-enabled packaging, TVCs, digital marketing and social media as part of a fully integrated campaign.

Food & Drink Business

Pure Wine Co has been appointed as the exclusive national mainland distributor for Tasmanian winery, Pipers Brook Vineyard. Effective from 1 March, Pure Wine Co will manage national mainland distribution and trade sales for Pipers Brook and its Kreglinger Sparkling, Pipers Tasmania and Ninth Island labels.

The fourth round of the federal government’s Traceability Grants Program is now open for applications, with funding from $50,000 to $500,000 available for projects modernising and enhancing agricultural traceability systems.

The rapid rise of GLP-1 weight loss medications is driving profound changes in consumer behaviour overseas – and Australia’s retail sector should prepare now. New data from Circana shows GLP-1 uptake has already reached meaningful scale in Australia, with 12 per cent of households reporting at least one member using a GLP-1 medication, as of September 2025.